- $303.77m
- $265.30m
- $191.44m
- 67
- 63
- 72
- 75
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4.57 | 14.8 | 62.5 | 240 | 191 |
Cost of Revenue | |||||
Gross Profit | -0.23 | -3.68 | 11.4 | 88.8 | 55.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 13.5 | 28.6 | 67.9 | 203 | 195 |
Operating Profit | -8.98 | -13.8 | -5.38 | 37.1 | -3.26 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -11.7 | -14.6 | -7.81 | 36.5 | -3.87 |
Provision for Income Taxes | |||||
Net Income After Taxes | -11.7 | -14.6 | -7.81 | 33.2 | -4.6 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -11.7 | -14.6 | -7.81 | 33.2 | -4.6 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -11.7 | -14.6 | -7.81 | 30.6 | -7.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.348 | -0.319 | -0.124 | 0.268 | -0.066 |